Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

APOLIPOPROTEIN A-I - ANVISA Registration 82444370073

Access comprehensive regulatory information for APOLIPOPROTEIN A-I in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 82444370073 and manufactured by DIAZYME LABORATORIES, INC.. The registration is held by Enzytec Biotecnologia Ltda. with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ORTHO CLINICAL DIAGNÓSTICS , INC., ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
82444370073
Registration Details
ANVISA Registration Number: 82444370073
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Família Diazyme Apolipoprotein A-I
Risk Class II

Registration Details

82444370073

25351634712202372

07214566000165

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Oct 30, 2023

VIGENTE

09/18/2025 19:00:01